Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 453289, 8 pages
http://dx.doi.org/10.1155/2015/453289
Research Article

Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells

1Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia
2Department of Oral Biology & Biomedical Sciences, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
3Institute of Nano Electronic Engineering (INEE) and School of Bioprocess Engineering, Universiti Malaysia Perlis, 01000 Kangar, Perlis, Malaysia
4Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
5Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
6Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 13 April 2015; Accepted 7 June 2015

Academic Editor: Marko Pesu

Copyright © 2015 Aik-Aun Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. D. Darbre, A. Aljarrah, W. R. Miller, N. G. Coldham, M. J. Sauer, and G. S. Pope, “Concentrations of parabens in human breast tumours,” Journal of Applied Toxicology, vol. 24, no. 1, pp. 5–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Thongprakaisang, A. Thiantanawat, N. Rangkadilok, T. Suriyo, and J. Satayavivad, “Glyphosate induces human breast cancer cells growth via estrogen receptors,” Food and Chemical Toxicology, vol. 59, pp. 129–136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. B. Gopinath, A. Matsugami, M. Katahira, and P. K. R. Kumar, “Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound,” Nucleic Acids Research, vol. 33, no. 15, pp. 4874–4881, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. C. B. Gopinath, R. Wadhwa, and P. K. R. Kumar, “Expression of noncoding vault RNA in human malignant cells and its importance in mitoxantrone resistance,” Molecular Cancer Research, vol. 8, no. 11, pp. 1536–1546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Isobe, S. Hisamori, D. J. Hogan et al., “miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway,” eLife, vol. 3, Article ID e01977, 2014. View at Publisher · View at Google Scholar
  6. A. J. Sasco, R. Kaaks, and R. E. Little, “Breast cancer: occurrence, risk factors and hormone metabolism,” Expert Review of Anticancer Therapy, vol. 3, no. 4, pp. 546–562, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kukreti, A. Cerussi, B. Tromberg, and E. Gratton, “Intrinsic near-infrared spectroscopic markers of breast tumors,” Disease Markers, vol. 25, no. 6, pp. 281–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. J. Hathaway, K. S. Butler, N. L. Adolphi et al., “Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors,” Breast Cancer Research, vol. 13, no. 5, article R108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. V. Nguyen and R. F. Saraf, “Tactile imaging of an imbedded palpable structure for breast cancer screening,” ACS Applied Materials & Interfaces, vol. 6, no. 18, pp. 16368–16374, 2014. View at Publisher · View at Google Scholar
  12. Z. Tehrani, G. Burwell, M. A. Azmi et al., “Generic epitaxial graphene biosensors for ultrasensitive detection of cancer risk biomarker,” 2D Materials, vol. 1, no. 2, Article ID 025004, 2014. View at Publisher · View at Google Scholar
  13. J. Musayev, C. Altiner, Y. Adiguzel, H. Kulah, S. Eminoglu, and T. Akin, “Capturing and detection of MCF-7 breast cancer cells with a CMOS image sensor,” Sensors and Actuators A: Physical, vol. 215, pp. 105–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Varki, “Biological roles of oligosaccharides: all of the theories are correct,” Glycobiology, vol. 3, no. 2, pp. 97–130, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Tan, A. K. Mu, L. V. Kiew, and Y. Chen, “Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy,” Cancer Cell International, vol. 14, no. 1, article 120, 2014. View at Publisher · View at Google Scholar
  16. R. Chen, Y. Tan, M. Wang et al., “Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma,” Molecular & Cellular Proteomics, vol. 10, no. 7, Article ID M110.006445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Heukeshoven and R. Dernick, “Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining,” Electrophoresis, vol. 6, no. 3, pp. 103–112, 1985. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Shevchenko, M. Wilm, O. Vorm, and M. Mann, “Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels,” Analytical Chemistry, vol. 68, no. 5, pp. 850–858, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Abdul Rahman, S. Anuar Karsani, I. Othman, P. Shafinaz Abdul Rahman, and O. Haji Hashim, “Galactose-binding lectin from the seeds of champedak (Artocarpus integer): sequences of its subunits and interactions with human serum O-glycosylated glycoproteins,” Biochemical and Biophysical Research Communications, vol. 295, no. 4, pp. 1007–1013, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Gruys, M. J. M. Toussaint, T. A. Niewold, and S. J. Koopmans, “Review: acute phase reaction and acute phase proteins,” Journal of Zhejiang University SCIENCE B, vol. 6, no. 11, pp. 1045–1056, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. A. Brooks, T. M. Carter, L. Royle et al., “Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies,” Anti-Cancer Agents in Medicinal Chemistry, vol. 8, no. 1, pp. 2–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. F. M. Tuccillo, A. de Laurentiis, C. Palmieri et al., “Aberrant glycosylation as biomarker for cancer: focus on CD43,” BioMed Research International, vol. 2014, Article ID 742831, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. N. Christiansen, J. Chik, L. Lee, M. Anugraham, J. L. Abrahams, and N. H. Packer, “Cell surface protein glycosylation in cancer,” Proteomics, vol. 14, no. 4-5, pp. 525–546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Saleemuddin and Q. Husain, “Concanavalin A: a useful ligand for glycoenzyme immobilization—a review,” Enzyme and Microbial Technology, vol. 13, no. 4, pp. 290–295, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. P. S. Abdul-Rahman, B.-K. Lim, and O. H. Hashim, “Expression of high-abundance proteins in sera patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods,” Electrophoresis, vol. 28, no. 12, pp. 1989–1996, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Huang, C. P. Reed, J. S. Zhang, V. Shridhar, L. Wang, and D. I. Smith, “Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells,” Cancer Research, vol. 59, no. 12, pp. 2981–2988, 1999. View at Google Scholar · View at Scopus
  27. T. Kayashima, K. Yamasaki, T. Yamada et al., “The novel imprinted carboxypeptidase A4 gene (CPA4) in the 7q32 imprinting domain,” Human Genetics, vol. 112, no. 3, pp. 220–226, 2003. View at Google Scholar · View at Scopus
  28. I. Pallarès, R. Bonet, R. García-Castellanos et al., “Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 11, pp. 3978–3983, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. G. W. Gettins, “Serpin structure, mechanism, and function,” Chemical Reviews, vol. 102, no. 12, pp. 4751–4804, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. V. P. Demidov, R. I. Iakubovskaia, T. A. Karmakova et al., “alpha 1-proteinase inhibitor in breast cancer,” Voprosy Onkologii, vol. 36, no. 1, pp. 23–29, 1990. View at Google Scholar
  31. J. Yavelow, A. Tuccillo, S. S. Kadner, J. Katz, and T. H. Finlay, “α1-Antitrypsin blocks the release of transforming growth factor-α from MCF-7 human breast cancer cells,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 3, pp. 745–752, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Blanchard, X. Liu, S. Eigel et al., “N-glycosylation and biological activity of recombinant human alpha1-antitrypsin expressed in a novel human neuronal cell line,” Biotechnology and Bioengineering, vol. 108, no. 9, pp. 2118–2128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Comunale, M. Lowman, R. E. Long et al., “Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma,” Journal of Proteome Research, vol. 5, no. 2, pp. 308–315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-K. Oh, D. L. Very, J. Walker, S. Raam, and S.-T. Ju, “An analogy between fetal haptoglobin and a potent immunosuppressant in cancer,” Cancer Research, vol. 47, no. 19, pp. 5120–5126, 1987. View at Google Scholar · View at Scopus
  35. F. P. Kuhajda, A. I. Katumuluwa, and G. P. Pasternack, “Expression of haptoglobin-related protein and its potential role as a tumor antigen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 4, pp. 1188–1192, 1989. View at Publisher · View at Google Scholar · View at Scopus
  36. S. A. Elg, L. F. Carson, J. M. Fowler, L. B. Twiggs, M. M. Moradi, and S. Ramakrishnan, “Ascites levels of haptoglobin in patients with ovarian cancer,” Cancer, vol. 71, no. 12, pp. 3938–3941, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. S. R. Harvey, S. K. Nayak, G. Markus et al., “Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin and β chains,” Archives of Biochemistry and Biophysics, vol. 345, no. 2, pp. 289–298, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Miyoshi and M. Nakano, “Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures,” Proteomics, vol. 8, no. 16, pp. 3257–3262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. U. M. Abd Hamid, L. Royle, R. Saldova et al., “A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression,” Glycobiology, vol. 18, no. 12, pp. 1105–1118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. R. P. Beckmann, L. A. Mizzen, and W. J. Welch, “Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly,” Science, vol. 248, no. 4957, pp. 850–854, 1990. View at Publisher · View at Google Scholar · View at Scopus
  41. J. E. Rothman and S. L. Schmid, “Enzymatic recycling of clathrin from coated vesicles,” Cell, vol. 46, no. 1, pp. 5–9, 1986. View at Publisher · View at Google Scholar · View at Scopus
  42. B. K. Shin, H. Wang, A. M. Yim et al., “Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function,” The Journal of Biological Chemistry, vol. 278, no. 9, pp. 7607–7616, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Evdokimovskaya, Y. Skarga, V. Vrublevskaya, and O. Morenkov, “Secretion of the heat shock proteins HSP70 and HSC70 by baby hamster kidney (BHK-21) cells,” Cell Biology International, vol. 34, no. 10, pp. 985–990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Nirdé, D. Derocq, M. Maynadier et al., “Heat shock cognate 70 protein secretion as a new growth arrest signal for cancer cells,” Oncogene, vol. 29, no. 1, pp. 117–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Sage, R. B. Vernon, S. E. Funk, E. A. Everitt, and J. Angello, “SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix,” The Journal of Cell Biology, vol. 109, no. 1, pp. 341–356, 1989. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Said, I. Najwer, and K. Motamed, “Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer,” The American Journal of Pathology, vol. 170, no. 3, pp. 1054–1063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Nagai, R. Gerhard, J. H. T. G. Fregnani et al., “Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients,” Breast Cancer Research and Treatment, vol. 126, no. 1, pp. 1–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. R.-L. Xie and G. L. Long, “Role of N-linked glycosylation in human osteonectin. Effect of carbohydrate removal by N-glycanase and site-directed mutagenesis on structure and binding of type V collagen,” The Journal of Biological Chemistry, vol. 270, no. 39, pp. 23212–23217, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Mills, P. B. Mills, P. T. Clayton, N. Mian, A. W. Johnson, and B. G. Winchester, “The underglycosylation of plasma α1-antitrypsin in congenital disorders of glycosylation type I is not random,” Glycobiology, vol. 13, no. 2, pp. 73–85, 2003. View at Publisher · View at Google Scholar · View at Scopus